H. Lundbeck A/S

Lundbeck shares rose 3.2% after pre‑announcing Q1 revenue 7% above consensus, driven by Vyepti, Abilify and Trintellix. Adjusted EBITDA exceeded forecasts by 23% thanks to higher gross margins, lower